Vairavan Latha Insider Trading Activity
Vairavan Latha has been net-selling over the last 12 months with 0 purchases and 7 sales across 1 company.
ARQT is the most-traded position with 7 trades. The largest single transaction was a sale of ARQT for $70K on Mar 2, 2026.
Performance Scorecard
Forward stock performance after each transaction by Vairavan Latha. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -2.4% | 57% | 7 |
| 90 days | — | -7.3% | 60% | 5 |
| 120 days | — | -18.0% | 40% | 5 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersARQT · Arcutis Biotherapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Vairavan Latha bought and sold ARQT.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 11, 2026 | ARQT | Sell | 435 | $21.05 | $9K | −0.5% | CFO | |
May 4, 2026 | ARQT | Sell | 1,341 | $23.61 | $32K | −1.5% | CFO | |
Mar 2, 2026 | ARQT | Sell | 2,772 | $25.16 | $70K | −3.1% | CFO | |
Mar 2, 2026 | ARQT | Sell | 81 | $25.91 | $2K | −0.1% | CFO | |
Feb 2, 2026 | ARQT | Sell | 1,320 | $25.50 | $34K | −2.0% | CFO | |
Nov 3, 2025 | ARQT | Sell | 88 | $24.72 | $2K | −0.1% | CFO | |
Aug 4, 2025 | ARQT | Sell | 89 | $14.33 | $1K | −0.1% | CFO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | 7 | $150K |
Other insiders at Arcutis Biotherapeutics, Inc.
6 other tracked filers at ARQT.